$658 Million is the total value of venBio Partners LLC's 8 reported holdings in Q3 2020. The portfolio turnover from Q2 2020 to Q3 2020 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ALXO | New | ALX ONCOLOGY HLDGS INC | $366,075,000 | – | 9,699,925 | +100.0% | 55.63% | – |
| HRMY | New | HARMONY BIOSCIENCES HLDGS IN | $118,807,000 | – | 3,504,624 | +100.0% | 18.06% | – |
| AKRO | Sell | AKERO THERAPEUTICS INC | $75,260,000 | -4.1% | 2,444,311 | -22.4% | 11.44% | -82.5% |
| CMPI | New | CHECKMATE PHARMACEUTICALS IN | $42,281,000 | – | 3,673,374 | +100.0% | 6.42% | – |
| MTCR | New | METACRINE INC | $31,234,000 | – | 3,059,123 | +100.0% | 4.75% | – |
| APLS | APELLIS PHARMACEUTICALS INC | $15,133,000 | -7.6% | 501,584 | 0.0% | 2.30% | -83.1% | |
| DTIL | Sell | PRECISION BIOSCIENCES INC | $7,997,000 | -65.6% | 1,298,191 | -53.5% | 1.22% | -93.7% |
| VRNA | Sell | VERONA PHARMA PLCsponsored ads | $1,242,000 | -41.9% | 199,075 | -56.4% | 0.19% | -89.4% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-11-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VERONA PHARMA PLC | 15 | Q2 2022 | 22.2% |
| AKERO THERAPEUTICS INC | 14 | Q3 2022 | 65.3% |
| ALX ONCOLOGY HLDGS INC | 13 | Q3 2023 | 73.8% |
| HARMONY BIOSCIENCES HLDGS IN | 13 | Q3 2023 | 21.1% |
| APELLIS PHARMACEUTICALS INC | 11 | Q2 2021 | 62.0% |
| PHARVARIS N V | 11 | Q3 2023 | 25.2% |
| IMPEL PHARMACEUTICALS INC | 10 | Q3 2023 | 7.3% |
| ELEVATION ONCOLOGY INC | 10 | Q3 2023 | 4.2% |
| VENTYX BIOSCIENCES INC | 8 | Q3 2023 | 42.7% |
| PRECISION BIOSCIENCES INC | 7 | Q3 2020 | 62.0% |
View venBio Partners LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
View venBio Partners LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.